Related Experiment Video
Updated: Jan 9, 2026

Transcranial Pulse Stimulation for Alzheimer's Patients
Published on: April 4, 2025
AI-augmented frameworks for enhancing Alzheimer's disease clinical trials: A memory clinic perspective
Francesco K Yigamawano1, Aubrey R Odom2, Chonghua Xue3
1Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA; Department of Biomedical Engineering, University of South Carolina, Columbia, SC, USA.
Artificial intelligence (AI) can significantly improve Alzheimer's disease (AD) clinical trial recruitment by automating patient identification and pre-screening. Implementing AI tools can accelerate the development of new therapies for AD patients.
Area of Science:
- Neurology
- Medical Informatics
Background:
- Alzheimer's disease (AD) clinical trials face significant patient recruitment challenges.
- These challenges lead to delayed timelines, underpowered studies, and increased costs.
Purpose of the Study:
- To explore the potential of artificial intelligence (AI) in overcoming patient identification hurdles in AD clinical trials.
- To examine the implementation considerations for AI-driven recruitment tools.
Main Methods:
- Perspective piece analyzing challenges from a memory clinic viewpoint.
- Discussion of AI applications including chatbots, decision support, and matching algorithms.
- Examination of data standardization, privacy, and ethical considerations.
Main Results:
- AI offers solutions for awareness, pre-screening, and patient-trial matching.
- Streamlining recruitment processes through AI automation is feasible.
- Critical considerations for AI tool development include data, privacy, and ethics.
Conclusions:
- AI has the potential to accelerate inclusive and efficient AD clinical trials.
- Thoughtful implementation of AI can expedite the delivery of therapies to patients.
- AI can help overcome major recruitment hurdles in Alzheimer's research.
More Related Videos
08:36The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
Published on: July 28, 2022
06:46Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
Published on: August 4, 2018
Related Concept Videos
Alzheimer's Disease: Treatment
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive Development During Adulthood
Dementia
The progression of dementia is generally gradual....